Work

Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors

Year: 2004

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdh188

Authors: G. Giaccone, J.L. González-Larriba, A.T. van Oosterom, R. Alfonso, E.F. Smit, M. Martens, G.J. Peters, W.J.F. van der Vijgh, R. Smith, S. Averbuch, A. Fandi

Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, Hospital Clínico San Carlos, Universitair Ziekenhuis Leuven, AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: AstraZeneca

OpenAlex ID: W2148673802

FWCI: 3.323

Cites: 24

Cited by: 58

Related to: 10